A cell culture-derived whole virus influenza A vaccine based on magnetic sulfated cellulose particles confers protection in mice against lethal influenza A virus infection
Vaccine purification and formulation with magnetic sulfated cellulose particles (MSCP). Influenza A virus MSCP vaccine for immunization of mice against lethal challenge. Purification and formulation of low-cost veterinary vaccines. Fast and simple purification for screening studies. Purification of viral vectors for gene therapy.